Gysella B. Muniz Pujalt, MD
- Assistant Professor of Pediatrics
- Medical Director, Newborn Nursery Service, UPMC Magee-Womens Hospital
- Regional Director, Quality Newborn Care, UPMC
Muniz is an Assistant Professor of Pediatrics in the Division of General Academic Pediatrics. She is a graduate of the Universidad San Martin de Porres in Lima, Peru. Muniz completed her internship, residency and chief residency at Georgetown University Hospital in Washington, DC.
Muniz is engaged in newborn care as UPMC's Regional Director of Quality Newborn Care and Medical Director of Newborn Nursery Services at UPMC Magee-Womens Hospital. Her quality improvement (QI) work is focused on decreasing variation and improving outcomes through the implementation of multiple clinical initiatives for neonatal hypothermia, neonatal hypoglycemia, breastfeeding initiation and neonatal abstinence syndrome (NAS). Muniz is involved in the development and implementation at a UPMC system wide level of Eat Sleep and Console (ESC), a novel assessment tool for newborns with NAS. She is also part of a skilled team developing and implementing an antibiotic stewardship program across multiple pediatric outpatient practices.
Through the Clinical Trials Unit at UPMC Children's Hospital of Pittsburgh, Muniz is deeply involved in several federally funded research studies focused on diagnosis and management of common pediatric infections such as otitis media, sinusitis, and urinary tract infections, as well as research related to newborn outcomes in at risk populations. Muniz is Chair of the Remote Village Project (VHCMB), an NGO that serves rural areas in Comayagua, Honduras. Her global health interests are related to indoor smoke pollution and community health care worker training.
Professional and Scientific Society Memberships
- American Academy of Pediatrics, 2013-Present
- Academic Pediatric Association, 2018-Present
Education & Training
- MD, Universidad de San Martín de Porres, 2004
- Unpaid Primary Care Physician, Peruvian Air Force Health Care System Rural Medical Service for Rural(SERUMS), 2004-2005
- Primary Care Volunteer, Hospital de Emergencias Pediátricas, 2005-2008
- Visiting Physician – Observer, MedStar Georgetown University Hospital, 2006
- Internship/Residency in Pediatrics, MedStar Georgetown University Hospital, 2008-2011
- Chief Resident, MedStar Georgetown University Hospital, 2011-2012
- NICU Hospitalist, MedStar Georgetown University Hospital, 2011
Martin, JM, Simonian A, Muniz G, Green M, Shaikh N. Comparison of Bacterial Culture Results Obtained from Nasopharyngeal and Mid-Turbinate Swabs in Children with Upper Respiratory Tract Infection Symptoms. Pediatr Infect Dis J. 2018 May 4. doi: 10.1097/INF.0000000000002027
Shaikh N, Hoberman A, Hum S, Alberty A, Muniz G, Kurs-Lasky M, Landsittel D, Shope TR. Predicting Urinary Tract Infections in Young Febrile Children: Development and Validation of a UTI Calculator. JAMA Pediatr. Published online April 16, 2018. doi:10.1001/jamapediatrics.2018.0217
Hoberman A, Paradise JL, Rockette HE, Jeong JH, Kearney DH, Bhatnagar S, Shope TR, Muniz G, Martin JM, Kurs-Lasky M, Haralam MA, Pope MA, Nagg JP, Zhao W, Kowser Miah M, Beumer J, Venkataramanan R, Shaikh N. Reduced-Concentration Clavulanate for Young Children with Acute Otitis Media. Antimicrob Ag Chemother, 2017 Jun 27;61(7).
Rennert WP, Porras Blanco RM, Muniz GB. The effects of smokeless cook stoves on peak expiratory flow rates in rural Honduras. J Public Health 2014; doi:10.1093/pubmed/fdu087
U01DC013995, Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media, (PI, 2.5% effort), 2015-2020, NIH/NICHD, $935,511
U01 AI118506, Efficacy of Antibiotics in Children with Acute Sinusitis: Which Subgroups Benefit?, (PI, 7% effort), 2015-2020, $975,370
A Study to Assess the Safety, Tolerability, and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months, (PI, 5.5% effort), 2018-2020, NOVUS Therapeutics, $1,039,598
Assessment of Bacterial and Viral Pathogens in Young Children with Acute Otitis Media (The TAP Study), (Pi, 10% effort), 2019-2022, Merck Sharp & Dohme Corp, $3,328,489
Medimmune Melody Study – A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody with an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY), (PI, 5% effort), 2019-2020, Industry sponsored Study Medimmune, $100 per year
Outpatient Pediatric Antimicrobial Stewardship Program: Optimizing Antimicrobial Prescription Choices and De-Labelling Drug Allergies in Community Offices, (PI, 50% effort), 2019-2021, Merck Sharp & Dohme Corp, $ Pre-Award status